Page last updated: 2024-10-17

creatine and Multiple Myeloma

creatine has been researched along with Multiple Myeloma in 15 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"Recently, the safety and effectiveness of bortezomib for patients with multiple myeloma and renal failure has been reported."7.77[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure]. ( Fujisaki, T; Kan, S; Murakami, H; Muta, T; Nakanishi, H; Senba, S; Ueda, Y; Yasunaga, M, 2011)
"Population pharmacokinetic modelling (using NONMEM) was performed with total and unbound concentration-time data from 100 patients (36-73 years) who had received a median 192 mg m(-2) melphalan dose."5.36Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. ( Duffull, SB; Earl, J; Gurney, H; Hegarty, G; Joshua, D; Kerridge, I; Kwan, YL; McLachlan, AJ; Nath, CE; Presgrave, P; Shaw, PJ; Tiley, C; Trotman, J; Zeng, L, 2010)
"Recently, the safety and effectiveness of bortezomib for patients with multiple myeloma and renal failure has been reported."3.77[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure]. ( Fujisaki, T; Kan, S; Murakami, H; Muta, T; Nakanishi, H; Senba, S; Ueda, Y; Yasunaga, M, 2011)
"Population pharmacokinetic modelling (using NONMEM) was performed with total and unbound concentration-time data from 100 patients (36-73 years) who had received a median 192 mg m(-2) melphalan dose."1.36Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy. ( Duffull, SB; Earl, J; Gurney, H; Hegarty, G; Joshua, D; Kerridge, I; Kwan, YL; McLachlan, AJ; Nath, CE; Presgrave, P; Shaw, PJ; Tiley, C; Trotman, J; Zeng, L, 2010)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19908 (53.33)18.7374
1990's2 (13.33)18.2507
2000's0 (0.00)29.6817
2010's5 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nooka, AK1
Harvey, RD1
Langston, A1
Collins, H1
Lonial, S1
Kaufman, JL1
Kim, M1
Ju, YS1
Lee, EJ1
Kang, HJ1
Kim, HS1
Cho, HC1
Kim, HJ1
Kim, JA1
Lee, DS1
Lee, YK1
Nath, CE1
Shaw, PJ1
Trotman, J1
Zeng, L1
Duffull, SB1
Hegarty, G1
McLachlan, AJ1
Gurney, H1
Kerridge, I1
Kwan, YL1
Presgrave, P1
Tiley, C1
Joshua, D1
Earl, J1
Muta, T1
Nakanishi, H1
Yasunaga, M1
Senba, S1
Murakami, H1
Kan, S1
Ueda, Y1
Fujisaki, T1
Cho, YU1
Chi, HS1
Park, CJ1
Jang, S1
Seo, EJ1
Suh, C1
HAHNEMANN, S1
FRIIS, T1
WATKIN, DM1
STEINFELD, JL1
SOLOMON, A1
FAHEY, JL1
Davis, FB1
Medway, W1
Weber, WT1
O'Brien, JA1
Krawitz, L1
Rico, H1
Hernandez, ER1
Diaz-Mediavilla, J1
Alvarez, A1
Martinez, R1
Espinos, D1
Durie, BG1
Stock-Novack, D1
Salmon, SE1
Finley, P1
Beckord, J1
Crowley, J1
Coltman, CA1
Williams, RC1
Brunning, RD1
Wollheim, FA1
Drivsholm, A1
Videbaek, A1
Guzzo, CE1
Pachas, WN1
Pinals, RS1
Krant, MJ1

Reviews

1 review available for creatine and Multiple Myeloma

ArticleYear
Myelomatous pleural effusion: a case series in a single institution and literature review.
    The Korean journal of laboratory medicine, 2011, Volume: 31, Issue:4

    Topics: Adenosine Deaminase; Adult; Aged; beta 2-Microglobulin; Chromosomes, Human, Pair 13; Creatine; Diagn

2011

Trials

1 trial available for creatine and Multiple Myeloma

ArticleYear
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.
    Blood, 1990, Feb-15, Volume: 75, Issue:4

    Topics: Age Factors; beta 2-Microglobulin; Calcium; Creatine; Humans; Multiple Myeloma; Multivariate Analysi

1990

Other Studies

13 other studies available for creatine and Multiple Myeloma

ArticleYear
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
    Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Creatine; Dose-Response Relationship, Drug; Female; Glomerular Fi

2014
Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma.
    Annals of laboratory medicine, 2016, Volume: 36, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Chromosome Aberrations; Chromosomes, Human, Pai

2016
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:5

    Topics: Adult; Aged; Area Under Curve; Creatine; Dose-Response Relationship, Drug; Female; Humans; Infusions

2010
[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:2

    Topics: Aged; Antineoplastic Agents; Boronic Acids; Bortezomib; Creatine; Female; Humans; Male; Middle Aged;

2011
[REABSORPTION OF PHOSPHORUS IN THE RENAL TUBULES IN NONPARATHYROGENOUS DISEASES].
    Nordisk medicin, 1964, May-07, Volume: 71

    Topics: Adenoma; Bone Neoplasms; Breast Neoplasms; Creatine; Creatinine; Denmark; Diagnosis, Differential; H

1964
METABOLIC RELATIONSHIPS BETWEEN TUMOR AND HOST DURING MASSIVE DOSES OF PREDNISONE IN HUMAN NEOPLASTIC DISEASE.
    Journal of the National Cancer Institute, 1964, Volume: 33

    Topics: 17-Ketosteroids; Adenocarcinoma; Biomedical Research; Blood; Calcium; Chlorides; Creatine; Creatinin

1964
BENCE JONES PROTEINEMIA.
    The American journal of medicine, 1964, Volume: 37

    Topics: Bence Jones Protein; Blood Protein Electrophoresis; Blood Sedimentation; Calcium; Calcium, Dietary;

1964
The treatment of hypercalcemia with inorganic phosphate salts.
    Journal of the American Geriatrics Society, 1967, Volume: 15, Issue:10

    Topics: Adult; Aged; Blood Urea Nitrogen; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Creatine; Fem

1967
Multiple myeloma in a dog.
    Journal of the American Veterinary Medical Association, 1967, Feb-15, Volume: 150, Issue:4

    Topics: Alkaline Phosphatase; Animals; Blood Proteins; Blood Sedimentation; Blood Urea Nitrogen; Bone Marrow

1967
Treatment of multiple myeloma with nasal spray calcitonin: a histomorphometric and biochemical study.
    Bone and mineral, 1990, Volume: 8, Issue:3

    Topics: Administration, Intranasal; Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Calci

1990
Light-chain disease. An abortive variant of multiple myeloma.
    Annals of internal medicine, 1966, Volume: 65, Issue:3

    Topics: Agammaglobulinemia; Bence Jones Protein; Blood Protein Electrophoresis; Bone Marrow; Bone Marrow Cel

1966
Alkeran (Melphalan) in the treatment of myelomatosis.
    Acta medica Scandinavica. Supplementum, 1966, Volume: 445

    Topics: Adult; Aged; Blood Platelets; Blood Proteins; Creatine; Female; Humans; Hypercalcemia; In Vitro Tech

1966
Urinary hydroxyproline excretion in patients with cancer.
    Cancer, 1969, Volume: 24, Issue:2

    Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Collagen; Creatine; Female; Humans;

1969